期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 416, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jns.2020.116974
关键词
Amyloid beta; senile plaques; amyloid precursor protein; blood-brain barrier; Alzheimer's disease
资金
- Deanship of Scientific Research at Princess Nourah bint Abdulrahman University
Amyloid beta (A beta) is an intricate molecule that interacts with several biomolecules and/or produces insoluble assemblies and eventually the nonphysiological depositions of its alternate with normal neuronal conditions leading to Alzheimer's disease (AD). A beta is formed through the proteolytic cleavage of the amyloid precursor protein (APP). Significant efforts are being made to explore the exact role of A beta in AD pathogenesis. It is believed that the deposition of A beta in the brain takes place from A beta components which are derived from the brain itself. However, recent evidence suggests that A beta derived also from the periphery and hence the A beta circulating in the blood is capable of penetrating the blood-brain barrier (BBB) and the role of A beta derived from the periphery is largely unknown so far. Therefore, A beta origin determination and the underlying mechanisms of its pathological effects are of considerable interest in exploring effective therapeutic strategies. The purpose of this review is to provide a novel insight into AD pathogenesis based on A beta in both the brain and periphery and highlight new therapeutic avenues to combat AD pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据